Abingdon Health
plc
("Abingdon" or "the Company")
CEO interview on the
Proactive Investors Platform
York, U.K. 15 March 2024: Abingdon Health plc (AIM: ABDX), a leading international
lateral flow contract development and manufacturing organization
(CDMO), is pleased to share a recent interview with Chris Yates,
CEO of Abingdon, on the Proactive Investors Platform.
Within this video Chris provides an
overview of the financial and operational highlights from Abingdon
interim results which were announced on the 14 March
2024.
Click on the link below to
watch:
https://www.proactiveinvestors.co.uk/companies/news/1043260/abingdon-health-ceo-discusses-strong-interim-results-robust-pipeline-and-growth-strategy-1043260.html
Enquiries
|
Abingdon Health plc
|
www.abingdonhealth.com/investors/
|
|
Chris Yates, Chief Executive Officer
|
|
|
Chris Hand, Non-Executive Chairman
|
|
|
|
|
|
|
|
|
Singer Capital Markets (Sole Broker and Nominated
Adviser)
|
Tel: +44
(0)20 7496 3000
|
|
Peter Steel, Alex Bond (Corporate
Finance)
|
|
|
Tom Salvesen (Corporate
Broking)
|
|
|
|
|
About Abingdon Health plc
Abingdon Health is a leading
lateral flow contract development and manufacturing organisation
(CDMO) offering its services to an international customer base
across industry sectors that include clinical, animal health, plant
health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to
routine and large-scale manufacturing; from "idea to commercial
success."
The Company's CDMO division offers
product development, regulatory support, technology transfer and
manufacturing services for customers looking to develop new assays
or transfer existing laboratory-based assays to a lateral flow
format. Abingdon Health aims to support the increase in
need for rapid results across many industries and locations and
produces lateral flow tests in areas such as infectious disease,
clinical testing including companion diagnostics, animal health and
environmental testing. Faster access to results allows for rapid
decision making, targeted intervention and can support better
outcomes.
Abingdon Health's Abingdon Simply
Test range of self-tests is an ecommerce platform that offers a
range of self-tests to empowers consumers to manage their own
health and wellbeing. The Abingdon Simply Test
ecommerce site offers consumers a range of
information to support them in making informed decisions on the
tests available. In addition, the site provides Abingdon's contract
services customers with a potential route to market for self-tests.
The Abingdon Simply Test range is also sold through international
distributors and through other channels in the UK and Ireland such
as pharmacy chains.
Founded in 2008, Abingdon
Health is headquartered in York, England.
For more information
visit: www.abingdonhealth.com